ArticleInternational journal of impotence research2026
Dorsal penile block of bupivacaine with adjuvant dexmedetomidine and dexamethasone can safely improve immediate post-operative analgesia and decrease opioid consumption after inflatable penile prosthesis surgery.
Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This single-institution, pre- post-intervention, retrospective study (2019-2021) compared the effect of dorsal penile nerve and ring block of 20 cc bupivacaine (0.25%) with and without dexmedetomidine (70 µg) + dexamethasone (4 mg) on pain scores, and both intra- and postoperative analgesia after primary inflatable penile prosthesis implantation. Dorsal penile nerve and ring block were completed with 10 cc of solution each, immediately before first incision. Anesthesia was not instructed to adjust their anesthetic plan for surgery. The primary outcomes were 11-point '0-10' numerical rating scale pain scores at 0, 2, 6, 12, 18, and 24 h postoperatively and cumulative narcotic use in those time windows. Secondary outcomes included intraoperative narcotic use, intraoperative hypotension (MAP < 60 for >5 min or requiring intervention), and intraoperative bradycardia (HR < 50 for >1 min). 98 patients met inclusion criteria. 32 were in the bupivacaine-only block (pre-intervention) group and 66 were in the bupivacaine, dexmedetomidine, dexamethasone combination block (post-intervention) group. Pain scores at all time points were significantly lower in the post-intervention than in the pre-intervention group (1.1 vs 3.8 p < 0.001, 1.6 vs 3.9 p < 0.001, 3.1 vs 4.9 p = 0.0047, 2.4 vs 4.3 p = 0.0011, 2.9 vs 5.3 p = 0.0047, 2.3 vs 4.4 p < 0.001). Cumulative postoperative narcotic requirement was lower for the post-intervention group (46.8 vs 65.5 mg oral morphine equivalents, p = 0.0067). Secondary outcomes (hypotension and bradycardia) were noted in 16 post-intervention cases, each mild and brief. Intraoperative penile block with bupivacaine and adjuvant dexmedetomidine and dexamethasone can safely improve immediate post-operative analgesia and decrease opioid consumption in the first 24 h.
Indexed as
Identifiers
41131407What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.